– USA, FL – Pediatrix Medical Group, Inc. (NYSE: MD) today announced the election of CEO Dr. Jim Swift (M.D.) to its Board of Directors effective March 8, 2023.
“Jim’s election follows his recent appointment as CEO. On behalf of the Board, I also want to honor Roger, a co-founder of Pediatrix, for all he has done for the Company and for millions of women, babies and children through his decades-long commitment to Take Great Care of the Patient,” said Executive chair, Mark Ordan.
About Pediatrix® Medical Group, Inc.
Pediatrix® Medical Group, Inc. is the nation’s leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate, and clinically excellent services to women, babies, and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine, and neonatology complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality improvement, and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through more than 5,000 affiliated physicians and other clinicians in 37 states.
SOURCE: https://www.pediatrix.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.